Stocktoria
ASSEMBLY BIOSCIENCES, INC. ASMB
ASSEMBLY BIOSCIENCES, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72.3M | $28.5M | $7.2M | $0 | $6.3M | $79.1M | $16.0M | $14.8M | $9.0M | $0 |
| R&D expense | $64.8M | $55.9M | $48.9M | $70.0M | $68.5M | $106.8M | $85.8M | $72.7M | $44.2M | $33.1M |
| Operating income | -$12.1M | -$45.4M | -$64.6M | -$94.1M | -$132.7M | -$64.8M | -$102.7M | -$92.7M | -$52.2M | -$45.3M |
| Income tax | $0 | $330,000 | $33,000 | $0 | -$2.5M | $0 | -$774,000 | $1.1M | -$9.1M | -$618,000 |
| Net income | -$6.1M | -$40.2M | -$61.2M | -$93.1M | -$129.9M | -$62.2M | -$97.6M | -$90.8M | -$42.8M | -$44.3M |
| EPS (diluted) | $-0.55 | $-6.69 | $-13.38 | $-23.08 | $-3.00 | — | — | — | — | — |
| Operating cash flow | -$41.1M | -$51.1M | $22.7M | -$84.5M | -$93.4M | -$63.0M | -$84.1M | -$65.0M | $1.9M | -$34.9M |
| Free cash flow | -$41.2M | -$51.1M | $22.5M | -$84.6M | -$96.5M | -$63.4M | -$85.6M | -$65.3M | $995,000 | -$35.0M |
| Cash & equivalents | $58.5M | $38.3M | $19.8M | $52.4M | $45.6M | $59.4M | $46.7M | $41.5M | $82.0M | $28.6M |
| Total assets | $257.6M | $119.2M | $136.8M | $101.8M | $191.1M | $283.3M | $339.9M | $268.0M | $169.3M | $98.1M |
| Total liabilities | $50.8M | $85.8M | $95.7M | $19.1M | $22.1M | $42.7M | $66.7M | $57.4M | $56.2M | $18.2M |
| Shareholders' equity | $206.8M | $33.4M | $41.1M | $82.7M | $168.9M | $240.6M | $273.2M | $210.7M | $113.1M | $79.9M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +153.5% | +298.2% | — | -100.0% | -92.1% | +395.6% | +7.8% | +64.1% | — | — |
| Free cash flow growth | — | -327.4% | — | — | — | — | — | -6662.6% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.